Back to Industry News
Medtech
B. Riley Files 10-K, But Nasdaq Listing Remains at Risk
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Bloomberg.com
Photo by Justin Ortega on Unsplash
Stay updated on stories like this
Key takeaways
- has submitted its delayed audited financial results for 2024, but will not meet the September 29 deadline for filing its quarterly reports this year, according to a Bloomberg report
- This development jeopardizes the company's listing on the Nasdaq stock exchange
- In a filing with the U
B. Riley Financial Inc. has submitted its delayed audited financial results for 2024, but will not meet the September 29 deadline for filing its quarterly reports this year, according to a Bloomberg report. This development jeopardizes the company's listing on the Nasdaq stock exchange.
In a filing with the U.S. Securities and Exchange Commission, B. Riley informed Nasdaq staff that it would be unable to submit the required quarterly reports by the deadline. Nasdaq had previously stipulated that the company must complete all outstanding filings – its annual Form 10-K and the first and second-quarter 10-Qs for the current year – to maintain its listing.
Related Topics
B. Riley FinancialNasdaq listing10-K filingregulatory compliancefinancial reporting
Never miss stories like this